REQUEST A DEMO
Total
USD $0.00
Search more companies

Texas Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Texas Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Texas Pharmaceuticals Private Limited is a company based in India, with its head office in Karnal. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on July 19, 2011. There was a net sales revenue increase of 3.22% reported in Texas Pharmaceuticals Private Limited’s latest financial highlights for 2025. Its’ total assets recorded a growth of 21.93%. In, 2025, the company’s net profit margin increased by 0.06%.

Legal Address
#87, Basement, Dayal Singh Colony, Karnal
Karnal; Haryana; Postal Code: 132001

Contact Details: Purchase the Texas Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Texas Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Texas Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 19, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Texas Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
3.22%
Total Operating Revenue
3.22%
Operating Profit
80.08%
EBITDA
55.9%
Net Profit/Loss for the Period
14.58%
Total Assets
21.93%
Total Equity
4.19%
Operating Profit Margin
0.88%
Net Profit Margin
0.06%
Return on Equity (ROE)
0.35%
Debt / Equity
5%
Quick Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?